Radiological Response and Characteristics of Patients Diagnosed With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: An Observational Study.

IF 1.6 Q3 GASTROENTEROLOGY & HEPATOLOGY
International Journal of Hepatology Pub Date : 2025-09-21 eCollection Date: 2025-01-01 DOI:10.1155/ijh/5821839
Valeska A Brito, Dayse C B L Aroucha, Andressa M Arruda, Ludmila C C Furtado, Victor P Fonseca, Paulo C R Oliveira-Filho, Emília L P C Branco, Maria F B L Brito, Leila M M B Pereira
{"title":"Radiological Response and Characteristics of Patients Diagnosed With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: An Observational Study.","authors":"Valeska A Brito, Dayse C B L Aroucha, Andressa M Arruda, Ludmila C C Furtado, Victor P Fonseca, Paulo C R Oliveira-Filho, Emília L P C Branco, Maria F B L Brito, Leila M M B Pereira","doi":"10.1155/ijh/5821839","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> Hepatocellular carcinoma (HCC), commonly associated with cirrhosis and factors such as viral hepatitis and metabolic disorders, is often diagnosed at advanced stages, influencing survival. Transarterial chemoembolization (TACE) is a primary therapeutic approach aimed at prolonging survival or serving as a link to liver transplantation. <b>Objective:</b> To identify factors associated with the response to TACE by modified Response Evaluation Criteria in Solid Tumors (mRECIST) in patients with HCC. <b>Materials and Methods:</b> This is a retrospective cohort study conducted at a Liver Institute in Brazil, including patients with HCC at Stages A and B treated with TACE from January 2011 to December 2021. Data were collected from electronic or digitized physical medical records and included demographic, clinical-laboratory, and tumor-related variables. Radiological response was assessed using mRECIST criteria. Statistical analysis encompassed various tests, with a significance level of 5%. <b>Results:</b> Seventy-six patients were evaluated, the majority being male (67.1%), with a median age of 62 years (57.0-70.0). Patients who responded to TACE showed a significant reduction in lesion size (<i>p</i> < 0.001) compared to the nonresponding group, resulting in lesion enlargement (<i>p</i> = 0.047). Only 38.2% of patients showed an objective response after the first TACE, with a trend towards a higher response in patients with stable disease (<i>p</i> < 0.001). Hepatitis C virus (HCV) etiology was associated with a higher chance of treatment response (<i>p</i> = 0.032). Initial disease staging was characterized by single tumors, while intermediate staging presented larger tumors after TACE. <b>Conclusion:</b> The association between HCV-induced cirrhosis and a better response to TACE underscores the importance of assessing liver function status in determining therapeutic response. No association was identified between pre-TACE alpha-fetoprotein levels and a higher likelihood of radiological response.</p>","PeriodicalId":46297,"journal":{"name":"International Journal of Hepatology","volume":"2025 ","pages":"5821839"},"PeriodicalIF":1.6000,"publicationDate":"2025-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476932/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/ijh/5821839","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Hepatocellular carcinoma (HCC), commonly associated with cirrhosis and factors such as viral hepatitis and metabolic disorders, is often diagnosed at advanced stages, influencing survival. Transarterial chemoembolization (TACE) is a primary therapeutic approach aimed at prolonging survival or serving as a link to liver transplantation. Objective: To identify factors associated with the response to TACE by modified Response Evaluation Criteria in Solid Tumors (mRECIST) in patients with HCC. Materials and Methods: This is a retrospective cohort study conducted at a Liver Institute in Brazil, including patients with HCC at Stages A and B treated with TACE from January 2011 to December 2021. Data were collected from electronic or digitized physical medical records and included demographic, clinical-laboratory, and tumor-related variables. Radiological response was assessed using mRECIST criteria. Statistical analysis encompassed various tests, with a significance level of 5%. Results: Seventy-six patients were evaluated, the majority being male (67.1%), with a median age of 62 years (57.0-70.0). Patients who responded to TACE showed a significant reduction in lesion size (p < 0.001) compared to the nonresponding group, resulting in lesion enlargement (p = 0.047). Only 38.2% of patients showed an objective response after the first TACE, with a trend towards a higher response in patients with stable disease (p < 0.001). Hepatitis C virus (HCV) etiology was associated with a higher chance of treatment response (p = 0.032). Initial disease staging was characterized by single tumors, while intermediate staging presented larger tumors after TACE. Conclusion: The association between HCV-induced cirrhosis and a better response to TACE underscores the importance of assessing liver function status in determining therapeutic response. No association was identified between pre-TACE alpha-fetoprotein levels and a higher likelihood of radiological response.

Abstract Image

Abstract Image

Abstract Image

经动脉化疗栓塞的肝癌患者的放射反应和特征:一项观察性研究。
肝细胞癌(HCC)通常与肝硬化和诸如病毒性肝炎和代谢紊乱等因素相关,通常在晚期诊断出来,影响生存。经动脉化疗栓塞(TACE)是一种主要的治疗方法,旨在延长生存期或作为肝移植的一个环节。目的:通过修订实体瘤反应评价标准(mRECIST),确定HCC患者对TACE反应的相关因素。材料和方法:这是一项在巴西肝脏研究所进行的回顾性队列研究,包括2011年1月至2021年12月接受TACE治疗的a期和B期HCC患者。数据从电子或数字化的物理医疗记录中收集,包括人口统计、临床实验室和肿瘤相关变量。使用mRECIST标准评估放射反应。统计分析包括多项检验,显著性水平为5%。结果:共评估76例患者,男性居多(67.1%),中位年龄62岁(57.0 ~ 70.0)。与无反应组相比,对TACE有反应的患者病变大小显著减小(p < 0.001),导致病变扩大(p = 0.047)。只有38.2%的患者在第一次TACE治疗后出现客观缓解,病情稳定的患者有更高的缓解趋势(p < 0.001)。丙型肝炎病毒(HCV)病因学与较高的治疗反应机会相关(p = 0.032)。疾病初期分期以单个肿瘤为特征,中期分期经TACE治疗后出现较大肿瘤。结论:丙型肝炎诱导的肝硬化与TACE更好的应答之间的关联强调了评估肝功能状态在确定治疗应答中的重要性。未发现tace前的甲胎蛋白水平与较高的放射反应可能性之间存在关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Hepatology
International Journal of Hepatology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
3.80
自引率
0.00%
发文量
11
审稿时长
15 weeks
期刊介绍: International Journal of Hepatology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the medical, surgical, pathological, biochemical, and physiological aspects of hepatology, as well as the management of disorders affecting the liver, gallbladder, biliary tree, and pancreas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书